Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel, proprietary ...

Galera Therapeutics shares are trading lower by 34.8% during Monday's session. The company said its shares will be delisted due to non-compliance with Nasdaq's continued listing standards.

Short interest in Galera Therapeutics Inc (OTC:GRTX) increased during the last reporting period, rising from 5.28K to 5.46K. This put 0.01% of the company's publicly available shares short.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Galera Therapeutics (OTC:GRTX), Inc. (OTC Pink Market:GRTX) held a Special Meeting of Stockholders on Thursday, where attendees voted against the proposed liquidation and dissolution of the company.

Featured here, the Income Statement (earnings report) for Galera Therapeutics Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses ...

Upgrade your Yahoo Finance plan to get complete details for Galera Therapeutics, Inc. Get advanced tools and insights to navigate the markets.